Format
Sort by

Send to:

Choose Destination

Results: 4

Related Articles by Review for PubMed (Select 21601373)

1.

Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases.

Shukla-Dave A, Lee NY, Jansen JF, Thaler HT, Stambuk HE, Fury MG, Patel SG, Moreira AL, Sherman E, Karimi S, Wang Y, Kraus D, Shah JP, Pfister DG, Koutcher JA.

Int J Radiat Oncol Biol Phys. 2012 Apr 1;82(5):1837-44. doi: 10.1016/j.ijrobp.2011.03.006. Epub 2011 May 19.

2.

Dynamic contrast-enhanced magnetic resonance imaging biomarkers in head and neck cancer: potential to guide treatment? A systematic review.

Bernstein JM, Homer JJ, West CM.

Oral Oncol. 2014 Oct;50(10):963-70. doi: 10.1016/j.oraloncology.2014.07.011. Epub 2014 Aug 10. Review.

PMID:
25116700
3.

[The state-of-the-art of the diagnosis of oral and oropharyngeal cancer].

Vikulova IuV.

Vestn Rentgenol Radiol. 2012 May-Jun;(3):51-4. Review. Russian. No abstract available.

PMID:
22997749
4.

Assessment of blood-brain barrier disruption using dynamic contrast-enhanced MRI. A systematic review.

Heye AK, Culling RD, Valdés Hernández Mdel C, Thrippleton MJ, Wardlaw JM.

Neuroimage Clin. 2014 Sep 10;6:262-74. doi: 10.1016/j.nicl.2014.09.002. eCollection 2014. Review.

Format
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk